Portola Pharmaceuticals, Inc. EBITDA Margin 2013-2020 | PTLA
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Portola Pharmaceuticals, Inc. (PTLA) over the last 10 years. The current EBITDA margin for Portola Pharmaceuticals, Inc. as of March 31, 2020 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2020-03-31 | $0.12B | $-0.25B | -209.17% |
| 2019-12-31 | $0.12B | $-0.27B | -229.31% |
| 2019-09-30 | $0.10B | $-0.26B | -257.84% |
| 2019-06-30 | $0.08B | $-0.29B | -365.82% |
| 2019-03-31 | $0.06B | $-0.33B | -603.64% |
| 2018-12-31 | $0.04B | $-0.34B | -860.00% |
| 2018-09-30 | $0.04B | $-0.34B | -980.00% |
| 2018-06-30 | $0.03B | $-0.35B | -1416.00% |
| 2018-03-31 | $0.03B | $-0.32B | -1264.00% |
| 2017-12-31 | $0.02B | $-0.27B | -1178.26% |
| 2017-09-30 | $0.03B | $-0.24B | -888.89% |
| 2017-06-30 | $0.03B | $-0.25B | -784.38% |
| 2017-03-31 | $0.03B | $-0.24B | -759.38% |
| 2016-12-31 | $0.04B | $-0.27B | -762.86% |
| 2016-09-30 | $0.03B | $-0.28B | -1108.00% |
| 2016-06-30 | $0.02B | $-0.24B | -1268.42% |
| 2016-03-31 | $0.02B | $-0.24B | -1423.53% |
| 2015-12-31 | $0.01B | $-0.22B | -2027.27% |
| 2015-09-30 | $0.01B | $-0.20B | -2177.78% |
| 2015-06-30 | $0.01B | $-0.18B | -2200.00% |
| 2015-03-31 | $0.01B | $-0.15B | -1850.00% |
| 2014-12-31 | $0.01B | $-0.13B | -1662.50% |
| 2014-09-30 | $0.01B | $-0.12B | -1487.50% |
| 2014-06-30 | $0.01B | $-0.10B | -1133.33% |
| 2014-03-31 | $0.01B | $-0.09B | -930.00% |
| 2013-12-31 | $0.01B | $-0.08B | -727.27% |
| 2013-09-30 | $0.01B | $-0.07B | -670.00% |
| 2013-06-30 | $0.07B | $0.00B | 2.70% |
